Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $348.70 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $248.52 | 9 | $0 (2024) |
| AbbVie Inc. | $100.18 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $102.37 | 4 | Amgen Inc. ($102.37) |
| 2023 | $113.24 | 4 | Amgen Inc. ($113.24) |
| 2022 | $32.91 | 1 | Amgen Inc. ($32.91) |
| 2021 | $100.18 | 1 | AbbVie Inc. ($100.18) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Inflammation | ||||||
| 06/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Inflammation | ||||||
| 04/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Inflammation | ||||||
| 12/20/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Inflammation | ||||||
| 06/19/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Inflammation | ||||||
| 03/06/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $35.78 | General |
| Category: Inflammation | ||||||
| 02/06/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Inflammation | ||||||
| 11/21/2022 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: Inflammation | ||||||
| 04/30/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $100.18 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,862 | 3,955 | $277,376 | $173,156 |
| 2022 | 12 | 668 | 1,223 | $74,260 | $50,730 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 231 | 285 | $29,239 | $18,302 | 62.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 272 | $24,252 | $16,562 | 68.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 44 | 48 | $23,295 | $15,738 | 67.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 286 | 449 | $30,100 | $15,046 | 50.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 38 | 48 | $20,208 | $14,597 | 72.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 161 | $20,271 | $14,307 | 70.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 173 | 173 | $19,197 | $11,183 | 58.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 93 | 130 | $14,594 | $10,166 | 69.7% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 31 | 31 | $12,460 | $9,277 | 74.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 261 | 1,849 | $13,113 | $9,005 | 68.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $14,026 | $8,860 | 63.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 110 | 189 | $9,705 | $7,165 | 73.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 39 | 46 | $7,764 | $5,645 | 72.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 39 | 49 | $13,602 | $5,437 | 40.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 34 | 36 | $4,580 | $2,905 | 63.4% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 22 | 23 | $6,238 | $2,334 | 37.4% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 12 | 13 | $3,783 | $1,923 | 50.8% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 15 | 15 | $4,831 | $1,780 | 36.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $4,097 | $1,590 | 38.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 36 | $2,021 | $1,334 | 66.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 109 | 123 | $12,510 | $8,778 | 70.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 113 | 113 | $12,487 | $8,575 | 68.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $9,696 | $6,688 | 69.0% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 17 | 17 | $8,361 | $5,810 | 69.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 113 | 135 | $8,947 | $4,436 | 49.6% |
About Dr. Tyler Enos, MD
Dr. Tyler Enos, MD is a Dermatology healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2017. The National Provider Identifier (NPI) number assigned to this provider is 1467988352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tyler Enos, MD has received a total of $348.70 in payments from pharmaceutical and medical device companies, with $102.37 received in 2024. These payments were reported across 10 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($348.70).
As a Medicare-enrolled provider, Enos has provided services to 2,530 Medicare beneficiaries, totaling 5,178 services with total Medicare billing of $223,886. Data is available for 2 years (2022–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Amarillo, TX
- Active Since 05/11/2017
- Last Updated 09/26/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1467988352
Products in Payments
- Otezla (Drug) $215.61
- SKYRIZI (Biological) $100.18
- Enbrel (Biological) $32.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Amarillo
Dr. Jason Jones, M.d, M.D
Dermatology — Payments: $4,504
Scott Miller, Md, MD
Dermatology — Payments: $3,758
Christi Baker, M.d, M.D
Dermatology — Payments: $3,294
Dr. Jacques Casparian, M.d, M.D
Dermatology — Payments: $1,981
Dr. William East
Dermatology — Payments: $778.54
Edward Mccarthy, Md, MD
Dermatology — Payments: $130.30